Rhythm Pharmaceuticals, Inc. (RYTM): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

64.98M
Year ended 2025-12-31
+7.6%
3-year compound annual growth
+8.0%
5-year compound annual growth
2019-12-31: 36.42M2020-12-31: 44.13M2021-12-31: 49.60M2022-12-31: 52.12M2023-12-31: 57.67M2024-12-31: 61.00M2025-12-31: 64.98M64.98M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3164.98M+6.5%2026-02-26, From 2025-01-01
2024-12-3161.00M+5.8%2026-02-26, From 2024-01-01
2023-12-3157.67M+10.7%2026-02-26, From 2023-01-01
2022-12-3152.12M+5.1%2024-02-29, From 2022-01-01
2021-12-3149.60M+12.4%2024-02-29, From 2021-01-01
2020-12-3144.13M+21.2%2023-03-01, From 2020-01-01
2019-12-3136.42Mn/a2022-03-01, From 2019-01-01